Cerebras Files for IPO: Nvidia’s AI Chip Rival Goes Public
Cerebras plans a Nasdaq IPO after strong growth, big AI deals, and rising demand for powerful chips competing with Nvidia.
Cerebras plans a Nasdaq IPO after strong growth, big AI deals, and rising demand for powerful chips competing with Nvidia.
CEOs removed risky share-backed loans, easing fears, as investors worry about private credit and withdrawals.
UBS starts coverage on Amneal Pharmaceuticals with a Buy rating. Strong specialty growth, Parkinson’s drugs, and attractive entry point after recent selloff.
Patrick and LCI may merge in an all-stock deal, creating a bigger RV parts maker. Talks are early, stock rose on news.
Intel stock is surging to 2000-era highs on strong gains, new deals, and turnaround hopes, up ~90% in 2026.
Ericsson missed forecasts, but core business is solid. Sales rose organically, cash flow strong, and AI + U.S. growth support long-term outlook.